Italy has just passed one million coronavirus positives: an average of 111 thousand cases per month, from March to November. Numbers that give more and more hope for the timeliness of the vaccine. But which ones have entered the final phase of experimentation? And especially, When they will be available in our country?
Covid, 10 vaccines are in the final phase of testing: what are they and what type
There are 10 vaccines in the final phase of testing, including the four Chinese and the Russian one. It should be noted that these products are of four different types:
- the first type includes those who use the inactivated virus (for example, one of the Chinese vaccines);
- the second type has the objective of introducing the protein spike synthesized that generates the immune response (among these are that of AstraZeneca and the US one of Johnson & Johnson);
- the third type encompasses those whose purpose is to inject sequences of Rna that cause cells to produce the spike protein, which in turn generates the immune response (includes Modern e Pfizer);
- the fourth type uses an RNA sequence of the virus that allows it to synthesize proteins or their fragments which, injected into the body with other substances, induce the immune response (this is the US vaccine of Novovax).
When we will have the anti-Covid vaccine in Italy
The big question that Italians ask themselves is when actually the vaccine, one of the many being tested, will arrive in Italy. Pfizer, AstraZeneca and Moderna have announced that the experimentation phase will soon end, also giving great vitality to the stock exchanges. The American FDA could give the green light to the administration in the USA already at the end of the year.
The European Mominstead, it will probably do so towards January because it has not yet been able to view the data from the human trials. Only then can the first doses arrive in Italy. In our country we should have enough because the EU Commission has signed contracts with all European and US companies that guarantee coverage to the entire population of the continent, including Italy.
Of course, they will be free because Europe has always financed part of the research and production. From the first published studies it would seem that vaccines will protect us from contagion, but also from the most undesirable effects of the disease, even if in Senior citizens and in people with serious diseases the immune barrier will be less solid, so it will be good to also vaccinate all those who attend them.
– .
